Ahluwalia Q2 FY27: PAT Falls 29% YoY to ₹56 Cr as Margins Compress, Revenue Up 24%
PAT -28.6% YoY · revenue +24.3% · margins compressing
₹1,463.66 Cr
+24.3% YoY
₹56.09 Cr
-28.6% YoY
3.8%
-2.1pp YoY
₹8.37
Ahluwalia Contracts' consolidated PAT fell 28.6% year-on-year to ₹56.09 Cr for Q2 FY27 (from ₹78.57 Cr in Q2 FY26), even as revenue from operations grew 24.3% YoY to ₹1,463.66 Cr (₹1,177.30 Cr a year ago). The quarter continues the margin story that has dominated the last two prints: topline is growing in line with, or ahead of, management's stated FY27 target, but profitability hasn't kept pace, with net margin compressing to 3.8% from 6.7% in Q2 FY26 (consolidated). Standalone tracked within 0.4% of consolidated (PAT ₹55.86 Cr), confirming the parent drives the group result; no exceptional items appear in either the current or comparative periods, so the YoY decline is operating, not one-off.
Q2 FY-2027 vs prior quarters
The squeeze sits on the operating line: our back-calculated EBITDA margin (OPM) was 7.58% this quarter, down roughly 335 bps from ~10.9% in Q2 FY26, driven by cost of materials consumed rising to 47.0% of revenue (from 40.4% a year ago), with sub-contract work holding near 29-30% of revenue in both periods. The relief, though, is sequential: OPM recovered to 7.58% from Q1 FY27's reported 4.3% — the multi-year low our pre-result preview flagged as 'the litmus test' for this quarter. On that basis the print delivers: PAT of ₹56.09 Cr beat the ₹40-50 Cr we'd estimated, revenue of ₹1,463.66 Cr cleared the ₹1,120-1,150 Cr range expected, and 7.58% OPM beat the 5-6% bar we'd set for 'relief.'
The stock went into the print at ₹528, down 8.9% over the past month of trading.
What the summary numbers don't show
EPS (basic, consolidated) ₹8.37 for the quarter vs ₹11.73 in Q2 FY26 and ₹1.55 in Q1 FY27.
FY27 revenue growth 12–15% (maintained 15%, NGT downside 12%). EBITDA margins ruled out for FY27; aspire for double-digit in FY28. Order inflow revised down to ₹4,000–5,000 Cr from ₹8,000 Cr.
— This quarter: beat
Management's prior guidance (Q1 FY27 concall, defensive tone) maintained FY27 revenue growth at 12-15%, explicitly ruled out double-digit EBITDA margins for FY27 (deferring that to FY28), and cut order-inflow guidance to ₹4,000-5,000 Cr from ₹8,000 Cr. H1 FY27 revenue of ₹2,589.48 Cr is up 18.7% YoY — running at the top of, or ahead of, that growth band — while this quarter's single-digit OPM is consistent with, not a miss against, the company's own margin caution. We found no Q2-specific analyst PAT consensus in public previews; the only quantified benchmark on record is our own pre-result estimate, against which this is a clear beat. Sell-side sentiment (10 of 11 analysts rated the stock BUY per our preview, median target ₹929) framed the margin pain as cyclical, with labour-cost normalisation expected in H2 — this quarter's sequential OPM recovery is an early, partial data point in that direction, not confirmation. Corporate activity this quarter — the ₹310 Cr Bennett University win (Oct 14) and the FY26 dividend payout (Oct 17) — is routine and doesn't materially move this print; the pending NCLT/NCLAT amalgamation appeal involving five subsidiaries remains unresolved before the Supreme Court, per the filing's notes.
W1
Whether OPM keeps climbing toward management's 'double-digit by FY28' aspiration — 7.6% this quarter is the new checkpoint.
W2
Order inflow against the revised ₹4,000-5,000 Cr FY27 guidance (cut from ₹8,000 Cr), tracked after the ₹310 Cr Bennett University win (Oct 14, 2026).
W3
Whether H2 FY27 revenue growth moderates toward the guided 12-15% band after H1's 18.7% YoY pace, or sustains the beat.
Informational and educational content only. Not investment advice.